• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

膜蛋白:癌细胞的关键参与者。

Membrane proteins: the key players of a cancer cell.

机构信息

Division of Pediatric Oncology/Hematology, Department of Pediatrics, Beatrix Children's Hospital, University Medical Center Groningen, The Netherlands.

出版信息

J Membr Biol. 2011 Jul;242(2):69-74. doi: 10.1007/s00232-011-9381-7. Epub 2011 Jul 6.

DOI:10.1007/s00232-011-9381-7
PMID:21732009
Abstract

Membrane proteins are involved in the prognosis of the most common forms of cancer. Membrane proteins are the hallmark of a cancer cell. The overexpressed membrane receptors are becoming increasingly important in cancer cell therapy. Current renewing therapy approaches based on receptor overexpression include; antibody therapy, nanocarrier drug delivery, and fluorescent tumor imaging in surgery. Gene profiling reveals cancer specific signatures and may identify membrane proteins that are related to cancer progression and lead to the development of improved therapy strategies in the future.

摘要

膜蛋白参与最常见癌症形式的预后。膜蛋白是癌细胞的标志。过表达的膜受体在癌细胞治疗中变得越来越重要。目前基于受体过表达的更新治疗方法包括:抗体治疗、纳米载体药物递送和手术中的荧光肿瘤成像。基因谱分析揭示了癌症特异性特征,并可能确定与癌症进展相关的膜蛋白,从而为未来开发改进的治疗策略提供依据。

相似文献

1
Membrane proteins: the key players of a cancer cell.膜蛋白:癌细胞的关键参与者。
J Membr Biol. 2011 Jul;242(2):69-74. doi: 10.1007/s00232-011-9381-7. Epub 2011 Jul 6.
2
Recognition Sites for Cancer-targeting Drug Delivery Systems.癌症靶向药物输送系统的识别位点。
Curr Drug Metab. 2019;20(10):815-834. doi: 10.2174/1389200220666191003161114.
3
ADAM10 as a target for anti-cancer therapy.ADAM10作为抗癌治疗的靶点。
Curr Pharm Biotechnol. 2008 Feb;9(1):2-8. doi: 10.2174/138920108783497613.
4
Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosis.以生物能量学为靶点增强癌症化疗:线粒体溶质载体蛋白与细胞凋亡
Cancer Biol Ther. 2009 Sep;8(17):1659-61. doi: 10.4161/cbt.8.17.9456. Epub 2009 Sep 7.
5
Applications of pHLIP Technology for Cancer Imaging and Therapy.pH 敏感脂质膜插入肽(pHLIP)技术在癌症成像与治疗中的应用
Trends Biotechnol. 2017 Jul;35(7):653-664. doi: 10.1016/j.tibtech.2017.03.014. Epub 2017 Apr 21.
6
Receptor mediated tumor targeting: an emerging approach for cancer therapy.受体介导的肿瘤靶向:癌症治疗的新方法。
Curr Drug Deliv. 2011 Jan;8(1):45-58. doi: 10.2174/156720111793663606.
7
The role of HER2 in cancer therapy and targeted drug delivery.HER2 在癌症治疗和靶向药物递送中的作用。
J Control Release. 2010 Sep 15;146(3):264-75. doi: 10.1016/j.jconrel.2010.04.009. Epub 2010 Apr 10.
8
Endogenous Stimuli-Responsive Nucleus-Targeted Nanocarrier for Intracellular mRNA Imaging and Drug Delivery.内源性刺激响应性核靶向纳米载体用于细胞内 mRNA 成像和药物递送。
ACS Appl Mater Interfaces. 2018 Nov 21;10(46):39524-39531. doi: 10.1021/acsami.8b16345. Epub 2018 Nov 6.
9
Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release.脂质体癌症治疗的先进策略:主动及肿瘤特异性药物释放的问题与前景
Prog Lipid Res. 2005 Jan;44(1):68-97. doi: 10.1016/j.plipres.2004.12.001. Epub 2005 Jan 22.
10
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets.能够通过美国食品药品监督管理局(FDA)审查的成功抗癌药物靶点显示出与随机基因和最初提出的靶点的特征不同的可识别特征。
Bioinformatics. 2008 Feb 1;24(3):389-95. doi: 10.1093/bioinformatics/btm447. Epub 2007 Oct 8.

引用本文的文献

1
Novel bioengineering strategies for drug delivery systems.药物递送系统的新型生物工程策略。
Appl Mater Today. 2023 Aug;33. doi: 10.1016/j.apmt.2023.101834. Epub 2023 Jun 9.
2
Investigation of Anticancer Peptides Derived from Species Using In Silico Analysis.利用计算机模拟分析对源自物种的抗癌肽进行研究。
Molecules. 2025 Apr 7;30(7):1640. doi: 10.3390/molecules30071640.
3
Computational investigation of missense somatic mutations in cancer and potential links to pH-dependence and proteostasis.计算研究癌症中的错义体细胞突变及其与 pH 依赖性和蛋白质平衡的潜在联系。

本文引用的文献

1
Intraoperative imaging in ovarian cancer: fact or fiction?卵巢癌术中影像学检查:事实还是虚构?
Mol Imaging. 2011 Aug;10(4):248-57. doi: 10.2310/7290.2011.00004. Epub 2011 Apr 26.
2
Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.利用靶向 αvβ3 整合素的近红外荧光剂实时成像增强手术视野。
Ann Surg Oncol. 2011 Nov;18(12):3506-13. doi: 10.1245/s10434-011-1664-9. Epub 2011 Apr 21.
3
Monitoring response and resistance to treatment in chronic myeloid leukemia.监测慢性髓性白血病的治疗反应和耐药性。
PLoS One. 2024 Nov 19;19(11):e0314022. doi: 10.1371/journal.pone.0314022. eCollection 2024.
4
Engineered Cancer Nanovaccines: A New Frontier in Cancer Therapy.工程化癌症纳米疫苗:癌症治疗的新前沿
Nanomicro Lett. 2024 Sep 30;17(1):30. doi: 10.1007/s40820-024-01533-y.
5
Natural Prenylflavones from the Stem Bark of : Promising Anticancer Agents for Oral Squamous Cell Carcinoma Targeting the Akt/mTOR/STAT-3 Signaling Pathway.来自[植物名称]茎皮的天然异戊烯基黄酮:靶向Akt/mTOR/STAT-3信号通路的口腔鳞状细胞癌的潜在抗癌剂
ACS Omega. 2024 May 24;9(23):24252-24267. doi: 10.1021/acsomega.3c08376. eCollection 2024 Jun 11.
6
Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities.计算膜蛋白作为抗癌靶点的特征:当前的挑战和机遇。
Int J Mol Sci. 2024 Mar 26;25(7):3698. doi: 10.3390/ijms25073698.
7
Unlocking Overexpressed Membrane Proteins to Guide Breast Cancer Precision Medicine.解锁过表达膜蛋白以指导乳腺癌精准医学
Cancers (Basel). 2024 Apr 3;16(7):1402. doi: 10.3390/cancers16071402.
8
Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras.阐明溶酶体靶向嵌合体靶向膜蛋白降解的细胞决定因素。
Science. 2023 Oct 20;382(6668):eadf6249. doi: 10.1126/science.adf6249.
9
CrMP-Sol database: classification, bioinformatic analyses and comparison of cancer-related membrane proteins and their water-soluble variant designs.CrMP-Sol 数据库:癌症相关膜蛋白及其水溶性变体设计的分类、生物信息学分析与比较。
BMC Bioinformatics. 2023 Sep 25;24(1):360. doi: 10.1186/s12859-023-05477-9.
10
Pan-cancer structurome reveals overrepresentation of beta sandwiches and underrepresentation of alpha helical domains.泛癌症结构基因组揭示了β三明治结构的过度表达和α螺旋结构域的表达不足。
Sci Rep. 2023 Jul 25;13(1):11988. doi: 10.1038/s41598-023-39273-5.
Curr Oncol. 2011 Apr;18(2):e71-83. doi: 10.3747/co.v18i2.391.
4
Novel α(2)β(1) integrin-targeted peptide probes for prostate cancer imaging.新型靶向α(2)β(1)整合素的肽探针用于前列腺癌成像。
Mol Imaging. 2011 Aug;10(4):284-94. doi: 10.2310/7290.2010.00044. Epub 2011 Apr 1.
5
Anti-EGFR monoclonal antibodies for treatment of colorectal cancers: development of cetuximab and panitumumab.用于治疗结直肠癌的抗表皮生长因子受体单克隆抗体:西妥昔单抗和帕尼单抗的研发
J Clin Pharmacol. 2012 Feb;52(2):128-55. doi: 10.1177/0091270010395940.
6
Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.Raf/MEK/ERK和PI3K/PTEN/Akt/mTOR信号通路在控制生长及对治疗的敏感性方面的作用——对癌症和衰老的启示
Aging (Albany NY). 2011 Mar;3(3):192-222. doi: 10.18632/aging.100296.
7
Potential mechanism of interleukin-8 production from lung cancer cells: an involvement of EGF-EGFR-PI3K-Akt-Erk pathway.肺癌细胞产生白细胞介素-8 的潜在机制:涉及表皮生长因子-表皮生长因子受体-PI3K-Akt-Erk 通路。
J Cell Physiol. 2012 Jan;227(1):35-43. doi: 10.1002/jcp.22722.
8
Near-infrared pH-activatable fluorescent probes for imaging primary and metastatic breast tumors.用于原发性和转移性乳腺癌成像的近红外 pH 激活型荧光探针。
Bioconjug Chem. 2011 Apr 20;22(4):777-84. doi: 10.1021/bc100584d. Epub 2011 Mar 9.
9
Chemoimmunotherapy with fludarabine and rituximab produces extended overall survival and progression-free survival in chronic lymphocytic leukemia: long-term follow-up of CALGB study 9712.氟达拉滨和利妥昔单抗的化疗免疫治疗可延长慢性淋巴细胞白血病的总生存期和无进展生存期:CALGB 研究 9712 的长期随访。
J Clin Oncol. 2011 Apr 1;29(10):1349-55. doi: 10.1200/JCO.2010.31.1811. Epub 2011 Feb 14.
10
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.PI3K 抑制导致 HER 信号增强,并导致 HER2 过表达的乳腺癌获得 ERK 依赖性。
Oncogene. 2011 Jun 2;30(22):2547-57. doi: 10.1038/onc.2010.626. Epub 2011 Jan 31.